Related Experiment Video
Updated: Jul 19, 2025

11:47
Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
Published on: January 22, 2017
10.6K
Targeting SARM1 improves autophagic stress-induced axonal neuropathy
Hye Ran Kim1, Hye Jin Lee1, Yewon Jeon2
1Peripheral Neuropathy Research Center (PNRC), Department of Molecular Neuroscience and Translational Biomedical Sciences, Dong-A University College of Medicine, Busan, Republic of Korea.
Autophagy
|August 10, 2023
Summary
This study reveals that sterile alpha and HEAT/Armadillo motif containing 1 (SARM1) deletion prevents axonal degeneration in Charcot-Marie-Tooth disease (CMT) models. This highlights SARM1 as a potential therapeutic target for CMT.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Charcot-Marie-Tooth disease (CMT) is a group of inherited peripheral neuropathies.
- Axonal degeneration is a key pathological feature in CMT, leading to progressive disability.
- Identifying molecular mechanisms driving axonal degeneration is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of sterile alpha and HEAT/Armadillo motif containing 1 (SARM1) in axonal degeneration in CMT.
- To evaluate the therapeutic potential of inhibiting SARM1 in CMT models.
Main Methods:
- Utilized conditional knockout (cKO) models to delete SARM1 in specific neuronal populations.
- Employed immunofluorescence (IF) and field emission scanning electron microscopy (FE-SEM) for detailed morphological analysis.
- Assessed nerve function using nerve conduction velocity (NCV) measurements.
Main Results:
- SARM1 deletion significantly protected axons from degeneration in CMT models.
- Conditional knockout of SARM1 in dorsal root ganglion (DRG) neurons prevented distal axonal loss.
- Nerve conduction velocity was preserved in SARM1-deficient CMT models.
Conclusions:
- SARM1 is a critical mediator of axonal degeneration in the context of CMT.
- Inhibition of SARM1 demonstrates significant neuroprotective effects in CMT models.
- Targeting SARM1 represents a promising therapeutic strategy for treating Charcot-Marie-Tooth disease.

